Provided by Tiger Trade Technology Pte. Ltd.

FUSEN PHARM

0.800
-0.105-11.60%
Volume:362.00K
Turnover:288.85K
Market Cap:591.20M
PE:-50.31
High:0.870
Open:0.830
Low:0.780
Close:0.905
52wk High:1.750
52wk Low:0.320
Shares:739.00M
HK Float Shares:739.00M
Volume Ratio:1.26
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.016
ROE:-3.25%
ROA:-0.46%
PB:1.41
PE(LYR):-50.31
PS:1.85

Loading ...

Fusen Pharmaceutical Sets 31 Aug 2026 Board Meeting to Review H1 Results and Potential Interim Dividend

Bulletin Express
·
Aug 19

Fusen Pharma Board to Review Interim Results, Consider Dividend

Reuters
·
Aug 19

FUSEN PHARM Keeps Issued Shares Steady at 739.30 Million in July 2026; Public Float Meets 25% Threshold

Bulletin Express
·
Aug 03

FUSEN PHARM (01652) Has Four Products Selected as Proposed Winners in China's National Drug Procurement

Stock News
·
Aug 03

FUSEN PHARM Announces Approval for Doxazosin Mesylate Sustained-Release Tablets

Stock News
·
Jul 10

Fusen Pharma Says China Regulator Clears Doxazosin Mesylate Extended-release Tablets for Marketing

Reuters
·
Jul 10

Fusen Pharma Shareholders Unanimously Approve RMB300 Million Capital Injection into Henan Subsidiary

Bulletin Express
·
Jul 09

Fusen Pharma Shareholders Back RMB 300 Million Target Unit Capital Increase Plan at EGM

Reuters
·
Jul 09

Fusen Pharma Gets Marketing Nod for Influenza Drug in China

MT Newswires Live
·
Jun 26

FUSEN PHARM: NMPA Green-Lights Peramivir Injection, Strengthening Anti-Influenza Lineup

Bulletin Express
·
Jun 26

Fusen Pharma Receives Approval for Peramivir Injection in China

Stock News
·
Jun 26

Fusen Pharmaceutical Co - Peramivir Injection First Neuraminidase Inhibitor Approved in China for Intravenous Influenza Treatment

THOMSON REUTERS
·
Jun 26

Fusen Pharm Calls 9 July 2026 EGM to Approve RMB 300.00 Million Capital Injection into Henan Subsidiary

Bulletin Express
·
Jun 23

Fusen Pharmaceutical announces extraordinary general meeting

Reuters
·
Jun 23

Fusen Pharmaceutical sells 34% stake in Henan Fusen unit for RMB 300 million in capital raise

Reuters
·
Jun 23

Fusen Pharma Unit to Raise 300 Million Yuan From State-Owned Investors

MT Newswires Live
·
Jun 19

BRIEF-Fusen Pharmaceutical Says Investors To Contribute RMB300 Mln For 34% Stake Subscription Of Henan Fusen Pharmaceutical

Reuters
·
Jun 18

Fusen Pharma Unit Secures CNY 300 Million Capital Injection

Stock News
·
Jun 18

Fusen Pharmaceutical schedules extraordinary general meeting

Reuters
·
Jun 18

Fusen Pharmaceutical Co - to Indirectly Retain 66% Stake in Henan Fusen Pharmaceutical

THOMSON REUTERS
·
Jun 18